메뉴 건너뛰기




Volumn 13, Issue 1, 2009, Pages 1-2

The Cambridge declaration: Towards clinical trials for drug-resistant tuberculosis

Author keywords

[No Author keywords available]

Indexed keywords

DRUG RESISTANT TUBERCULOSIS; EDITORIAL; MEDICAL RESEARCH; MULTIDRUG RESISTANT TUBERCULOSIS; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

EID: 58149386065     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial
Times cited : (9)

References (7)
  • 1
    • 57649172884 scopus 로고    scopus 로고
    • World Health Organization, WHO/HTM/TB/2007.387. Geneva, Switzerland: WHO
    • World Health Organization. The global MDR-TB & XDR-TB response plan 2007-2008. WHO/HTM/TB/2007.387. Geneva, Switzerland: WHO, 2007.
    • (2007) The global MDR-TB & XDR-TB response plan 2007-2008
  • 2
    • 58149373984 scopus 로고    scopus 로고
    • World Health Organization. Anti-tuberculosis drug resistance in the world: fourth global report. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008.
    • World Health Organization. Anti-tuberculosis drug resistance in the world: fourth global report. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008.
  • 4
    • 33746928758 scopus 로고    scopus 로고
    • Treatment of multidrug-resistant tuberculosis: Evidence and controversies
    • Caminero J. Treatment of multidrug-resistant tuberculosis: evidence and controversies. Int J Tuberc Lung Dis 2006; 10: 829-837.
    • (2006) Int J Tuberc Lung Dis , vol.10 , pp. 829-837
    • Caminero, J.1
  • 5
    • 43949084039 scopus 로고    scopus 로고
    • NIAID Tuberculosis Working Group. Multidrug-resistant and extensively drug-resistant tuberculosis: The National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research
    • Fauci A S, NIAID Tuberculosis Working Group. Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research. J Infect Dis 2008; 197: 1493-1498.
    • (2008) J Infect Dis , vol.197 , pp. 1493-1498
    • Fauci, A.S.1
  • 6
    • 58149389492 scopus 로고    scopus 로고
    • Treatment Action Group, October 15, Paris, France. Available at: Accessed November 2008
    • Treatment Action Group. Funding trends in TB research & development: 2005-2007. Preliminary report, October 15, 2008, Paris, France. Available at: http://www.treatmentactiongroup.org/WorkArea/linkit.aspx?LinkIdentifier= id&ItemID=2602 Accessed November 2008.
    • (2008) Funding trends in TB research & development: 2005-2007. Preliminary report
  • 7
    • 58149385824 scopus 로고    scopus 로고
    • The Cambridge Declaration: towards clinical trials for drug-resistant tuberculosis. Cambridge, MA, USA. June 12, 2008. http://www.ghdonline.org/drtb/ resource/the-cambridge-declaration-towards-clinical-trials-/ Accessed November 2008.
    • The Cambridge Declaration: towards clinical trials for drug-resistant tuberculosis. Cambridge, MA, USA. June 12, 2008. http://www.ghdonline.org/drtb/ resource/the-cambridge-declaration-towards-clinical-trials-/ Accessed November 2008.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.